Apollo Hospitals Share Price

Apollo Hospitals Enterprise Limited is an Indian healthcare chain headquartered in Chennai. It was founded in 1983 by Prathap C Reddy. Apollo Hospitals has become a leading integrated healthcare service provider in Asia with a strong presence throughout various healthcare domains. This includes hospitals, pharmacies, primary care and diagnostic clinics, as well as multiple retail health models.

The market capitalisation of Apollo Hospitals Enterprise Limited is over ₹81,000 crore as of December 27, 2023. Apollo Hospitals share price has gained more than 130% in three years.

Business operations

Apollo Hospitals was established in Chennai. The chain has now evolved into the most extensive integrated healthcare ecosystem. Currently, it operates 70 hospitals, 5541 pharmacies and 530 clinics, along with 1750 diagnostic centres, day surgery units and birthing centres across India.

Apollo Hospitals has an extensive offline pharmacy network with 5,541 outlets spanning across 21 states and 4 Union Territories. It is the leading retail healthcare network in the country comprising 343 primary clinics, 58 sugar clinics, 129 dental clinics, 26 birthing centres and 1750 diagnostic centres.

Apollo is among the first chains to introduce the concept of corporate healthcare delivery in India. This group leads the way as a premier private-sector healthcare provider in Asia. Its operations include the ownership and management of a comprehensive network comprising specialty hospitals, clinics, and a widespread chain of pharmacy retail outlets across the nation.

Apollo Hospitals services span across cardiology and cardiothoracic surgery, orthopaedics and joint replacement surgery, spine surgery, oncology, medical and surgical gastroenterology, neurology and neurosurgery, nephrology, urology and critical care medicine.

The group extends its reach through telemedicine facilities in numerous countries, offers health insurance services, engages in global projects consultancy, operates medical colleges and e-learning platforms like medvarsity.

Services such as ASK Apollo, an online consultation portal, and Apollo Home Health contribute to providing more comprehensive healthcare services.

Another of its products, Apollo 24X7, has made the entire range of services accessible through mobile devices. It ensures the swift home delivery of medications within 2 hours across over 19,000 pincodes in India. The platform facilitates virtual consultations with top specialists and super-specialists.. It also organises the home collection of diagnostic samples through a wide phlebotomy network.

One of its key features is the EMR system, which functions as a digital health repository. Apollo 24/7 has more than 25 million registered users.

Financial Highlights

• Apollo Hospitals Enterprise Limited's revenue from operations for FY23 was ₹16,612.5 crore, up from ₹14,662.6 crore in FY22.
• The company recorded a PAT (profit after tax) of ₹819.1 crore in FY23 against ₹1,055.6 crore in FY22.
• In FY23, the earnings before interest, taxes, depreciation and amortisation (EBITDA) decreased to ₹1,850.9 crore from the previous year's ₹2,003.5 crore.
• The company's earnings per share (EPS) stood at ₹56.97 in FY23 compared to ₹73.42 in the previous financial year.

25 September 2025 – Apollo Hospitals Share Price Update

As of last trading day, Apollo Hospitals opened at ₹7,698.00 and last traded at ₹7,643.50, showing a fall of 40.50 points (0.53%) compared to the previous close of ₹7,684.00. During the session, the stock touched a high of ₹7,730.00 and a low of ₹7,634.50. The company's market capitalization now stands at ₹1,09,902 Crs, with a P/E ratio of 73.5 and a dividend yield of 0.19%.